{"result": "(\"entity\"<|>HOSPITAL UNIVERSITARIO LA FE<|>ORGANIZATION<|>Hospital Universitario la Fe is a healthcare institution in the Generalitat Valenciana that provides guidelines for artificial nutrition in adults.)\n##\n(\"entity\"<|>GENERALITAT VALENCIANA<|>ORGANIZATION<|>Generalitat Valenciana is the regional government of Valencia, Spain, responsible for healthcare policies including nutrition guidelines.)\n##\n(\"entity\"<|>INTENSIVE CARE MEDICINE<|>EVENT<|>Intensive Care Medicine refers to the medical specialty that deals with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and monitoring.)\n##\n(\"entity\"<|>CRITICAL ILLNESS<|>EVENT<|>Critical Illness refers to a state of health where a patient is at risk of death and requires intensive medical care.)\n##\n(\"entity\"<|>COPD<|>EVENT<|>Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease that causes breathing difficulties and is often treated with nutritional support.)\n##\n(\"entity\"<|>GLUTAMINE<|>EVENT<|>Glutamine is an amino acid that is sometimes used in the nutritional support of critically ill patients, although its efficacy is debated.)\n##\n(\"entity\"<|>ARGININE<|>EVENT<|>Arginine is an amino acid that serves as a precursor for nitric oxide and is considered for use in patients with acute lung injury.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support refers to the provision of nutrients to patients who are unable to meet their nutritional needs through normal eating.)\n##\n(\"entity\"<|>MICRONUTRIENTS<|>EVENT<|>Micronutrients are vitamins and minerals that are essential for the bodyâ€™s proper functioning, particularly in patients with respiratory issues.)\n##\n(\"entity\"<|>SDRA<|>EVENT<|>SDRA stands for Acute Respiratory Distress Syndrome, a severe condition that requires specific nutritional management.)\n##\n(\"entity\"<|>EVIDENCE-BASED APPROACH<|>EVENT<|>An evidence-based approach refers to making clinical decisions based on the best available research evidence.)\n##\n(\"entity\"<|>DOIG GS<|>PERSON<|>Doig GS is an author of a meta-analysis on early enteral nutrition in critically ill patients.)\n##\n(\"entity\"<|>FERREIRA IM<|>PERSON<|>Ferreira IM is an author of a meta-analysis on nutritional support for individuals with COPD.)\n##\n(\"entity\"<|>CREUTZBERG EC<|>PERSON<|>Creutzberg EC is an author who studied the nonresponse to high caloric oral nutritional therapy in patients with COPD.)\n##\n(\"entity\"<|>PAUL EM<|>PERSON<|>Paul EM is an author discussing enteral nutrition myths and misconceptions in critically ill patients.)\n##\n(\"entity\"<|>HEYLAND D<|>PERSON<|>Heyland D is an author of a randomized trial on glutamine and antioxidants in critically ill patients.)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARIO LA FE<|>GENERALITAT VALENCIANA<|>Hospital Universitario la Fe operates under the guidelines set by the Generalitat Valenciana for artificial nutrition<|>7)\n##\n(\"relationship\"<|>INTENSIVE CARE MEDICINE<|>CRITICAL ILLNESS<|>Intensive Care Medicine is the specialty that manages patients in critical illness<|>8)\n##\n(\"relationship\"<|>COPD<|>NUTRITIONAL SUPPORT<|>Nutritional support is often necessary for patients suffering from COPD<|>6)\n##\n(\"relationship\"<|>GLUTAMINE<|>NUTRITIONAL SUPPORT<|>Glutamine is considered for use in the nutritional support of critically ill patients<|>5)\n##\n(\"relationship\"<|>ARGININE<|>NUTRITIONAL SUPPORT<|>Arginine is evaluated for its role in nutritional support for patients with acute lung injury<|>5)\n##\n(\"relationship\"<|>SDRA<|>NUTRITIONAL SUPPORT<|>Nutritional support is critical for managing patients with SDRA<|>7)\n##\n(\"relationship\"<|>DOIG GS<|>INTENSIVE CARE MEDICINE<|>Doig GS conducted a meta-analysis relevant to practices in Intensive Care Medicine<|>6)\n##\n(\"relationship\"<|>FERREIRA IM<|>COPD<|>Ferreira IM's research focuses on nutritional support for individuals with COPD<|>6)\n##\n(\"relationship\"<|>CREUTZBERG EC<|>COPD<|>Creutzberg EC's study addresses nutritional therapy in patients with COPD<|>6)\n##\n(\"relationship\"<|>PAUL EM<|>INTENSIVE CARE MEDICINE<|>Paul EM discusses enteral nutrition in the context of Intensive Care Medicine<|>6)\n##\n(\"relationship\"<|>HEYLAND D<|>INTENSIVE CARE MEDICINE<|>Heyland D's trial on glutamine is relevant to practices in Intensive Care Medicine<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: se reco-mienda la administraciÃ³n de 200-300 mg/kg/dÃ­a de N2 o 1-1.5 g/kg/dÃ­a de proteÃ­nas. Tan sÃ³lo pueden ser necesarias mayores cantidades en el SDRA con paciente muy hipercatabÃ³lico (1.5-2 g/kg/dÃ­a), recomendaciÃ³n ex-tensiva a los enfermos que sean sometidos a ventilaciÃ³n mecÃ¡nica para favorecer su retirada. Hay estudios que recomiendan los aminoÃ¡ci-dos de cadena ramificada ya que incrementan la respuesta ventilatoria, con descenso del CO2.\n\nAunque no hay ninguna evidencia cientÃ­fica que avale aÃ±adir el aminoÃ¡cido glutam-ina en la nutriciÃ³n de estos pacientes, la justificaciÃ³n para utilizarla se basa en el ex-ceso de consumo de glutamina en la cÃ©lula endotelial, por la respuesta a TNFe IL-1.\n\nDe la misma manera que el aporte de glutamina , el uso de arginina en pacientes con lesiÃ³n pulmonar aguda y SDRA, no es concluyente. La arginina es un aminoÃ¡ci-do precursor del Ã³xido nÃ­trico y el sustrato en la sÃ­ntesis de las cÃ©lulas endoteliales pulmonares logrando una vasodilataciÃ³n importante pulmonar, siendo Ã©sta la justi-ficaciÃ³n para su uso.\n\n## Micronutrientes:\n\nEstos aportes favorecen la funciÃ³n de los mÃºsculos respiratorios y la respuesta an-tioxidativa.\n\nLos pacientes con patologÃ­a pulmonar primaria o secundaria parecen ser especial-mente sensibles a la hipofosfatemia. Se ha demostrado una disminuciÃ³n del fÃ³sforo muscular en pacientes con broncopatÃ­a crÃ³nica. La hipofosfatemia afecta tambiÃ©n al transporte de oxÃ­geno, por ello debe monitorizarse regularmente la concentraciÃ³n de fÃ³sforo sÃ©rico en pacientes con insuficiencia respiratoria aguda, especial-mente en aquellos que requieren ventilaciÃ³n mecÃ¡nica y nutriciÃ³n artificial.\n\nAsimismo en pacientes con SDRA es importante el aporte de Î±-tocoferol, selenio y otros antioxidantes como vitaminas A, C y E sobre todo si se utilizan Ã¡cidos grasos poliinsaturados. En caso de aporte de grasa con alto Ã­ndice Ï‰-3/Ï‰-6, los suplemen-tos de vitamina E y selenio podrÃ­an prevenir la peroxidaciÃ³n lipÃ­dica.\n\nSe recomienda la restricciÃ³n de agua y sodio en los pacientes con cor pulmonale.\n\nDebe prestarse especial atenciÃ³n al aporte de potasio, fÃ³sforo, magnesio y antiox-idantes en los pacientes con insuficiencia respiratoria crÃ³nica, con un nivel de evi-dencia en las guÃ­as C.\n---\n# REQUERIMIENTOS NUTRICIONALES DE LA INSUFICIENCIA RESPIRATORIA AGUDA (IRA).\n\n| | IRA (VentilaciÃ³n Asistida) | SDRA |\n|---|---|---|\n| EnergÃ­a | 20-25 Kcal/peso ideal/dÃ­a . EcuaciÃ³n de Harris-Benedict X factor estrÃ©s 0.9/1.1 | 25 Kcal/peso ideal/dÃ­a |\n| GlÃºcidos | 50-60%    â‰¤ 4g/kg/dÃ­a | 50-60%    â‰¤ 4g/kg/dÃ­a |\n| LÃ­pidos | 30-40%   (1-1.5 g/kg/dÃ­a). | 40-50%   (1-1.5 g/kg/dÃ­a). |\n| ProteÃ­nas | 1-1.5 g/kg/dÃ­a | 1.5-2 g/kg/dÃ­a |\n| Micronutrientes | Vigilar niveles de fÃ³sforo sÃ©rico | , Î±- tocoferol, selenio, vitaminas A, C y E |\n---\n# BIBLIOGRAFIA\n\n1. GuÃ­a de Nutricion Artificial en el adulto. Hospital Universitario la Fe. Generalitat Valenciana. 1997.\n\n2. Doig GS,Heigjes PT, Simponson F, Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomized controlled trials. Intensive Care Med.2009; 35:2018-27.\n\n3. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS. Nutricional support for individuals with COPD: a meta-analysis. Chest 2000; 117:672-8\n\n4. Creutzberg EC,Schols AM, Weling-Scheepers CA,Buurman WA,Wouters EF.Characterizacion of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2000; 161:745-52.\n\n5. Svetang VD, Stephen AMcC, Todd WR. Nutrition in the ICU an Evidence-Based Approach. CHEST 2014; 145): 1148 â€“ 1157.\n\n6. Paul EM. Enteral Nutrition in the Critically Ill: Myths and Misconceptions. Crit Care Med 2014; 42:962â€“969.\n\n7. Heyland D, Muscedere J, Wischmeyer PE. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}